Novavax Inc (NVAX) 6.77 $NVAX Uptrend Call Work
Post# of 273330
Posted On: 09/03/2016 7:17:11 AM
Novavax Inc (NVAX) 6.77 $NVAX
Uptrend Call Working As Novavax Stock Rises 30.8% (NVAX)
Comtex SmarTrend(R) - Fri Aug 26, 1:28PM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 3 months, Novavax has returned 30.76% as of today's recent price of $7.12.
NVAX: 6.77 (-0.05)
Novavax Up 26.5% Since SmarTrend Uptrend Call (NVAX)
Comtex SmarTrend(R) - Thu Aug 11, 1:28PM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 3 months, Novavax has returned 26.54% as of today's recent price of $6.89.
NVAX: 6.77 (-0.05)
Novavax Set to Possibly Rebound After Yesterday's Selloff of 9.84%
Comtex SmarTrend(R) - Wed Aug 10, 2:01PM CDT
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $6.81 to a high of $7.37. Yesterday, the shares fell 9.8%, which took the trading range below the 3-day low of $7.46 on volume of 7.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NVAX: 6.77 (-0.05)
Novavax Reports Second Quarter 2016 Financial Results
GlobeNewswire - Tue Aug 09, 3:08PM CDT
Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2016.
NVAX: 6.77 (-0.05)
Novavax Has Returned 39.8% Since SmarTrend Recommendation (NVAX)
Comtex SmarTrend(R) - Thu Aug 04, 12:51AM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 2 months, Novavax has returned 39.76% as of today's recent price of $7.61.
NVAX: 6.77 (-0.05)
Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 9, 2016
GlobeNewswire - Tue Aug 02, 3:07PM CDT
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it will report its second quarter 2016 financial and operating results after the close of U.S. financial markets on Tuesday, August 9, 2016.
NVAX: 6.77 (-0.05)
35.5% Return Seen to Date on SmarTrend Novavax Call (NVAX)
Comtex SmarTrend(R) - Wed Jul 27, 1:10PM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 2 months, Novavax has returned 35.49% as of today's recent price of $7.38.
NVAX: 6.77 (-0.05)
Interesting NVAX Put And Call Options For August 19th
DividendChannel.com - Tue Jun 21, 9:38AM CDT
Investors in Novavax, Inc. saw new options begin trading this week, for the August 19th expiration.
NVAX: 6.77 (-0.05)
Novavax Recognized by Washington Post as Top Workplace
GlobeNewswire - Fri Jun 17, 7:30AM CDT
Novavax, Inc. (Nasdaq:NVAX), today announced that, for the third consecutive year, it has been recognized as a Top Workplace for 2016.
NVAX: 6.77 (-0.05)
Novavax Has Returned 24.3% Since SmarTrend Recommendation (NVAX)
Comtex SmarTrend(R) - Fri Jun 17, 1:08AM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 3 weeks, Novavax has returned 24.33% as of today's recent price of $6.77.
NVAX: 6.77 (-0.05)
Novavax Rises 2.81% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 15, 3:05PM CDT
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $6.59 to a high of $6.90. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $6.64 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NVAX: 6.77 (-0.05)
23.4% Return Seen to Date on SmarTrend Novavax Call (NVAX)
Comtex SmarTrend(R) - Thu Jun 09, 1:55PM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 2 weeks, Novavax has returned 23.42% as of today's recent price of $6.72.
NVAX: 6.77 (-0.05)
Novavax Announces New Seasonal Combination Respiratory Vaccine Program
Globe Newswire - Thu Jun 02, 3:11PM CDT
- Seasonal influenza nanoparticle approach replaces VLP program
NVAX: 6.77 (-0.05)
Novavax Rises 6.66% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue May 31, 5:08PM CDT
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $5.93 to a high of $6.29. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $6.06 on volume of 4.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NVAX: 6.77 (-0.05)
U.S. FDA Grants Fast Track Designation to Novavax' RSV F Vaccine for Older Adults
Globe Newswire - Wed May 25, 7:01AM CDT
GAITHERSBURG, Md., May 25, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate (RSV F Vaccine) for the protection of older adults (60 years of age and older).
NVAX: 6.77 (-0.05)
After Yesterday's Rally of 2.48% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon May 23, 4:22PM CDT
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $5.26 to a high of $5.47. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $5.31 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NVAX: 6.77 (-0.05)
Uptrend Call Working As Novavax Stock Rises 30.8% (NVAX)
Comtex SmarTrend(R) - Fri Aug 26, 1:28PM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 3 months, Novavax has returned 30.76% as of today's recent price of $7.12.
NVAX: 6.77 (-0.05)
Novavax Up 26.5% Since SmarTrend Uptrend Call (NVAX)
Comtex SmarTrend(R) - Thu Aug 11, 1:28PM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 3 months, Novavax has returned 26.54% as of today's recent price of $6.89.
NVAX: 6.77 (-0.05)
Novavax Set to Possibly Rebound After Yesterday's Selloff of 9.84%
Comtex SmarTrend(R) - Wed Aug 10, 2:01PM CDT
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $6.81 to a high of $7.37. Yesterday, the shares fell 9.8%, which took the trading range below the 3-day low of $7.46 on volume of 7.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NVAX: 6.77 (-0.05)
Novavax Reports Second Quarter 2016 Financial Results
GlobeNewswire - Tue Aug 09, 3:08PM CDT
Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2016.
NVAX: 6.77 (-0.05)
Novavax Has Returned 39.8% Since SmarTrend Recommendation (NVAX)
Comtex SmarTrend(R) - Thu Aug 04, 12:51AM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 2 months, Novavax has returned 39.76% as of today's recent price of $7.61.
NVAX: 6.77 (-0.05)
Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 9, 2016
GlobeNewswire - Tue Aug 02, 3:07PM CDT
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it will report its second quarter 2016 financial and operating results after the close of U.S. financial markets on Tuesday, August 9, 2016.
NVAX: 6.77 (-0.05)
35.5% Return Seen to Date on SmarTrend Novavax Call (NVAX)
Comtex SmarTrend(R) - Wed Jul 27, 1:10PM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 2 months, Novavax has returned 35.49% as of today's recent price of $7.38.
NVAX: 6.77 (-0.05)
Interesting NVAX Put And Call Options For August 19th
DividendChannel.com - Tue Jun 21, 9:38AM CDT
Investors in Novavax, Inc. saw new options begin trading this week, for the August 19th expiration.
NVAX: 6.77 (-0.05)
Novavax Recognized by Washington Post as Top Workplace
GlobeNewswire - Fri Jun 17, 7:30AM CDT
Novavax, Inc. (Nasdaq:NVAX), today announced that, for the third consecutive year, it has been recognized as a Top Workplace for 2016.
NVAX: 6.77 (-0.05)
Novavax Has Returned 24.3% Since SmarTrend Recommendation (NVAX)
Comtex SmarTrend(R) - Fri Jun 17, 1:08AM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 3 weeks, Novavax has returned 24.33% as of today's recent price of $6.77.
NVAX: 6.77 (-0.05)
Novavax Rises 2.81% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 15, 3:05PM CDT
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $6.59 to a high of $6.90. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $6.64 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NVAX: 6.77 (-0.05)
23.4% Return Seen to Date on SmarTrend Novavax Call (NVAX)
Comtex SmarTrend(R) - Thu Jun 09, 1:55PM CDT
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 24th, 2016 at $5.45. In approximately 2 weeks, Novavax has returned 23.42% as of today's recent price of $6.72.
NVAX: 6.77 (-0.05)
Novavax Announces New Seasonal Combination Respiratory Vaccine Program
Globe Newswire - Thu Jun 02, 3:11PM CDT
- Seasonal influenza nanoparticle approach replaces VLP program
NVAX: 6.77 (-0.05)
Novavax Rises 6.66% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue May 31, 5:08PM CDT
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $5.93 to a high of $6.29. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $6.06 on volume of 4.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NVAX: 6.77 (-0.05)
U.S. FDA Grants Fast Track Designation to Novavax' RSV F Vaccine for Older Adults
Globe Newswire - Wed May 25, 7:01AM CDT
GAITHERSBURG, Md., May 25, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate (RSV F Vaccine) for the protection of older adults (60 years of age and older).
NVAX: 6.77 (-0.05)
After Yesterday's Rally of 2.48% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon May 23, 4:22PM CDT
Novavax (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $5.26 to a high of $5.47. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $5.31 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NVAX: 6.77 (-0.05)
(0)
(0)